Mesenchymal stromal stem cells, commonly called MSCs, have been among the most-studied cell types in regenerative medicine over the past two decades. They have been tested in hundreds of clinical trials for conditions ranging from joint degeneration to heart disease, autoimmune disorders, lung injury, and complications after transplantation. MSCs have consistently been shown to be…
If you or someone you care about has been diagnosed with a stem cell therapy for spinal cord injury, you understand how life-altering the challenges can be. At Stemedix, we work with patients who have already received a confirmed diagnosis and are seeking alternative ways to support their recovery goals. While no treatment guarantees a…
Autoimmune and rheumatic diseases affect millions of people worldwide and can involve the joints, skin, gut, nervous system, and many other organs. Conditions like regenerative medicine for rheumatoid arthritis, stem cell therapy for osteoarthritis, lupus, stem cell therapy for inflammatory bowel disease disease, stem cell therapy for multiple sclerosis, and Sjögren’s syndrome often cause regenerative…
Low back pain is one of the most common health problems worldwide. It affects quality of life, limits work and daily activities, and creates a significant economic burden. In many adults, especially those over age 50, a key driver of this pain is lumbar intervertebral disc degeneration. When the disc between the vertebrae begins to…
Aging is a universal biological process marked by the gradual decline of physiological function across all organ systems. It is driven by a combination of genetic, environmental, and molecular factors that influence the rate of deterioration from birth onward. Although inevitable, scientific progress in regenerative medicine has identified potential ways to mitigate its effects and…
Pulmonary fibrosis is a chronic and progressive lung disease marked by abnormal scarring of the tissue surrounding the air sacs. This process thickens and stiffens the lungs, leading to shortness of breath, fatigue, and reduced oxygen exchange. Current medications, such as pirfenidone and nintedanib, can slow disease progression but do not reverse tissue damage. As…
Mesenchymal stem cells (MSCs) are at the forefront of regenerative medicine, offering significant therapeutic potential due to their self-renewal, multipotency, and immunomodulatory properties. These nonhematopoietic adult stem cells can differentiate into various mesodermal lineages, including bone, cartilage, and adipose cells, while influencing immune and inflammatory pathways. As part of this review, Han et al. explore…
Alzheimer’s disease (AD) is the most common cause of dementia, gradually destroying memory, learning, and functional independence. Current FDA-approved drugs such as donepezil, rivastigmine, galantamine, and memantine provide limited symptomatic relief but do not slow the progression of neuronal loss. Antibody therapies that target amyloid plaques have shown inconsistent regenerative medicine for neurodegenerative conditions outcomes.…
stem cell therapy for Parkinson disease’s disease (PD) is one of the most common neurodegenerative conditions, second only to Alzheimer’s. It primarily affects the basal nuclei of the brain, leading to the gradual loss of dopamine-producing neurons and the buildup of abnormal protein clusters called Lewy bodies. Together, these changes cause the classic motor and…
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease that causes irreversible damage to the alveoli and leads to pulmonary interstitial fibrosis. stem cell therapy for lung disease with IPF often experience severe difficulty breathing, which can result in respiratory failure and death. The disease is challenging to diagnose, has a high mortality rate,…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!